Search
forResearch 10 of 1000+
- Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Alopecia areata following COVID-19 vaccine: a systematic review
- Letter in Reply: Alopecia areata after SARS-CoV-2 vaccination
- Alopecia Areata after COVID-19 Vaccines
- A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme
- Medication-induced hair loss: An update
- BH07 The socioeconomic burden of alopecia areata
Community 1
Learn
— no results
Try a deeper search in learn →